Genesco (NYSE: GCO) reported Q3 EPS of $0.79, $0.09 worse than the analyst estimate of $0.88. Revenue for the quarter came in at $616 million versus the consensus estimate of $618.62 million.

For Fiscal 2026, while the Company expects sales and operating income growth to last year, we are revising our outlook and lowering guidance:

Now expects total sales to be up about 2% and comparable sales to be up about 3% compared to Fiscal 2025, down from prior guidance for total sales to be up 3% to 4% and comparable sales up 4% to 5%
Now expects adjusted diluted earnings per share from continuing operations to be around $0.952, down from our prior expectation of $1.30 to $1.70
Guidance assumes no further share repurchases and a tax rate of 34% excluding the tax impact of OBBBA, up from prior guidance of 29%

For earnings history and earnings-related data on Genesco (GCO) click here.